Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A45720 | 23108300 | Dig Dis | Promotion of hepatocellular carcinoma by hepatitis C virus. | 2012 | Details |
| A45721 | 23099228 | Dig Liver Dis | Author reply: comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property". | 2012 | Details |
| A45722 | 23093702 | Endocrinology | Additive effects of nicotine and high-fat diet on hepatic steatosis in male mice. | 2012 | Details |
| A45723 | 23070526 | Sleep Breath | Obstructive sleep apnea and dyslipidemia: importance of the liver axis. | 2012 | Details |
| A45724 | 23069475 | J Hepatol | From lung to liver: how does airborne particulate matter trigger NASH and systemic insulin resistance? | 2012 | Details |
| A45725 | 23058851 | Dig Liver Dis | Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property". | 2012 | Details |
| A45726 | 23053554 | Am J Clin Nutr | Mitigating factors and metabolic mechanisms in fructose-induced nonalcoholic fatty liver disease: the next challenge. | 2012 | Details |
| A45727 | 23047983 | Am J Physiol Endocrinol Metab | Maternal androgen excess reduces placental and fetal weights, increases placental steroidogenesis, and leads to long-term health effects in their female offspring. | 2012 | Details |
| A45728 | 23038652 | Hepatology | Nonalcoholic fatty liver disease (NAFLD): is it really a serious condition? | 2012 | Details |
| A45729 | 23035112 | J Biol Chem | Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. | 2012 | Details |
| A45730 | 23034023 | N Engl J Med | Clinical problem-solving. An intricate interplay. | 2012 | Details |
| A45731 | 23008852 | Korean J Gastroenterol | [Practice guideline for the diagnosis and management of non-alcoholic fatty liver disease]. | 2012 | Details |
| A45732 | 31186870 | Clin Liver Dis (Hoboken) | Liver transplantation and nonalcoholic fatty liver disease. | 2012 | Details |
| A45733 | 31186869 | Clin Liver Dis (Hoboken) | Management of nonalcoholic fatty liver disease in children. | 2012 | Details |
| A45734 | 31186868 | Clin Liver Dis (Hoboken) | Pediatric nonalcoholic fatty liver disease: Prevalence, diagnosis, risk factors, and management. | 2012 | Details |
| A45735 | 31186866 | Clin Liver Dis (Hoboken) | Management of nonalcoholic fatty liver disease: Role of bariatric surgery. | 2012 | Details |
| A45736 | 31186865 | Clin Liver Dis (Hoboken) | Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exercise. | 2012 | Details |
| A45737 | 31186864 | Clin Liver Dis (Hoboken) | Assessment and management of comorbidities (including cardiovascular disease) in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A45738 | 31186863 | Clin Liver Dis (Hoboken) | Natural history of nonalcoholic fatty liver disease. | 2012 | Details |
| A45739 | 31186862 | Clin Liver Dis (Hoboken) | Histological assessment of nonalcoholic fatty liver disease in adults and children. | 2012 | Details |
| A45740 | 31186861 | Clin Liver Dis (Hoboken) | Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers. | 2012 | Details |
| A45741 | 31186860 | Clin Liver Dis (Hoboken) | Nonalcoholic fatty liver disease: Definitions, risk factors, and workup. | 2012 | Details |
| A45742 | 22992889 | Endocrine | Ghrelin: a new treatment for non-alcoholic fatty liver disease? | 2012 | Details |
| A45743 | 22991197 | Hepatology | Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib. | 2013 | Details |
| A45744 | 22988590 | Zhonghua Gan Zang Bing Za Zhi | [Role of sex hormones in nonalcoholic fatty liver disease pathogenesis]. | 2012 | Details |
| A45745 | 22985643 | Gastrointest Endosc | Endoluminal bariatric therapy: beyond weight loss. | 2012 | Details |
| A45746 | 22978400 | Curr Drug Metab | Editorial: lipohepatotoxicity and nonalcoholic steatohepatitis (NASH)-like metabolic disorders. | 2012 | Details |
| A45747 | 22974850 | Transplant Proc | Preliminary study of early histomorphometric changes in hepatic steatosis. | 2012 | Details |
| A45748 | 22973707 | Nihon Naika Gakkai Zasshi | [The cutting-edge of medicine; recent topics of NASH]. | 2012 | Details |
| A45749 | 22964154 | Zhonghua Gan Zang Bing Za Zhi | [Simvastatin inhibits activation of hepatic stellate cells and promotes activation of adenosine monophosphate-activated protein kinase]. | 2012 | Details |
| A45750 | 22963060 | Am Fam Physician | Weight loss for patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A45751 | 22960075 | Am J Pathol | The glucagon-like peptide-1 receptor agonist Exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis. | 2012 | Details |
| A45752 | 22957215 | J Obes | An update on less invasive and endoscopic techniques mimicking the effect of bariatric surgery. | 2012 | Details |
| A45753 | 22940010 | J Hepatol | Impact of subclinical hypothyroidism on the development of non-alcoholic fatty liver disease: a prospective case-control study. | 2012 | Details |
| A45754 | 22939493 | Rev Gastroenterol Mex | [Fatty liver, alcoholic steatohepatitis, and non-alcoholic steatohepatitis]. | 2012 | Details |
| A45755 | 25755448 | J Clin Exp Hepatol | Coffee and liver - long way to go. | 2012 | Details |
| A45756 | 22923470 | Diabetes | Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. | 2012 | Details |
| A45757 | 22921094 | Am J Obstet Gynecol | Nutrient sensor-mediated programmed nonalcoholic fatty liver disease in low birthweight offspring. | 2012 | Details |
| A45758 | 22917635 | Dig Liver Dis | Comment on "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property". | 2012 | Details |
| A45759 | 22909420 | Dig Liver Dis | Author reply: comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property". | 2012 | Details |
| A45760 | 22904613 | Biologics | Hepatocellular carcinoma: natural history, current management, and emerging tools. | 2012 | Details |
| A45761 | 22891562 | Pol Merkur Lekarski | [Evaluation of alpha-fetoprotein concentration in patients with chronic liver diseases]. | 2012 | Details |
| A45762 | 22882641 | Diabet Med | Fatty liver: cause or consequence. | 2012 | Details |
| A45763 | 22877991 | Biochim Biophys Acta | Physiological roles of phosphatidylethanolamine N-methyltransferase. | 2012 | Details |
| A45764 | 22876570 | J Pediatr Endocrinol Metab | Diagnosis of non-alcoholic fatty liver disease in obese children. | 2012 | Details |
| A45765 | 22866321 | Bull Exp Biol Med | Simulation of nonalcoholic steatohepatitis in rats. | 2012 | Details |
| A45766 | 22864231 | Circ J | Coronary flow reserve evaluated by quantitative perfusion magnetic resonance imaging in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A45767 | 22862874 | Mayo Clin Proc | Why vitamin D status should be checked in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A45768 | 22858195 | Nutrition | Nonalcoholic fatty liver disease as a pro-resolution defective disorder. | 2012 | Details |
| A45769 | 22855658 | Case Rep Gastroenterol | Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis. | 2012 | Details |
| A45770 | 22848224 | Int J Microbiol | Microbial translocation in chronic liver diseases. | 2012 | Details |
| A45771 | 22840429 | Atherosclerosis | Non-alcoholic fatty liver disease and cardiovascular disease. | 2012 | Details |
| A45772 | 22824486 | Clin Liver Dis | Preface. Advances and evolving concepts in nonalcoholic fatty liver disease. | 2012 | Details |
| A45773 | 22823912 | J Gastroenterol Hepatol | Enhancing organ pool by statins: is this the future? | 2012 | Details |
| A45774 | 22814966 | Hepatology | Glycogen synthase kinase 3-mediated voltage-dependent anion channel phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation. | 2013 | Details |
| A45775 | 22813567 | Diabetes Metab Syndr | Insulin resistance and alanine amino transaminase (ALT) levels in first degree relatives of type 2 diabetes mellitus. | 2012 | Details |
| A45776 | 22811431 | Physiol Rev | Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. | 2012 | Details |
| A45777 | 22801991 | Endocrine | Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block. | 2012 | Details |
| A45778 | 22801389 | Curr Opin Lipidol | Hepatic steatosis and VLDL hypersecretion. | 2012 | Details |
| A45779 | 22801247 | J Investig Med | Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes. | 2012 | Details |
| A45780 | 22793999 | Antioxid Redox Signal | Mitochondrial morphology in metabolic diseases. | 2012 | Details |
| A45781 | 22792473 | Int J Hepatol | Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity. | 2012 | Details |
| A45782 | 22773852 | J Neurol Neurosurg Psychiatry | Neurological picture. Acquired hepatocerebral degeneration revealed by neurogenic hyperventilation syndrome and myelitis. | 2012 | Details |
| A45783 | 22764879 | Liver Int | Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. | 2012 | Details |
| A45784 | 22763792 | Curr Gastroenterol Rep | Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases? | 2012 | Details |
| A45785 | 22760649 | Semin Liver Dis | The burden of liver disease in human immunodeficiency virus-infected patients. | 2012 | Details |
| A45786 | 22751293 | Pol Arch Med Wewn | Comment on "Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease". | 2012 | Details |
| A45787 | 22738945 | J Pediatr | Treating pediatric nonalcoholic fatty liver disease with cysteamine: is adiponectin the key? | 2012 | Details |
| A45788 | 22729849 | Hepatology | Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle. | 2012 | Details |
| A45789 | 22723765 | Gastroenterol Hepatol (N Y) | Cryoglobulins in nonalcoholic Fatty-liver disease: what is the association? | 2012 | Details |
| A45790 | 22723561 | Radiology | Liver steatosis: concordance of MR imaging and MR spectroscopic data with histologic grade. | 2012 | Details |
| A45791 | 22722428 | Dig Dis | Epidemic trends of obesity with impact on metabolism and digestive diseases. | 2012 | Details |
| A45792 | 22715101 | J Biol Chem | The ABCG5 ABCG8 sterol transporter opposes the development of fatty liver disease and loss of glycemic control independently of phytosterol accumulation. | 2012 | Details |
| A45793 | 22701473 | Exp Diabetes Res | Molecular intricacies and the role of ER stress in diabetes. | 2012 | Details |
| A45794 | 22701308 | J Biomed Biotechnol | Think small: zebrafish as a model system of human pathology. | 2012 | Details |
| A45795 | 22696903 | Trop Gastroenterol | Is liver biopsy still the gold standard for diagnosing liver fibrosis? | 2012 | Details |
| A45796 | 22696577 | Am J Physiol Regul Integr Comp Physiol | Potential clinical translation of juvenile rodent inactivity models to study the onset of childhood obesity. | 2012 | Details |
| A45797 | 22686718 | Natl Med J India | Atorvastatin and antioxidants: the remedy for non-alcoholic fatty liver disease? | 2012 | Details |
| A45798 | 22680320 | Natl Med J India | Mortality and non-alcoholic fatty liver disease: type of study cohort matters! | 2012 | Details |
| A45799 | 22680081 | Natl Med J India | Alcohol for patients with non-alcoholic fatty liver disease: friend or foe? | 2012 | Details |
| A45800 | 22675634 | Biochem Res Int | Inhibition of the Mitochondrial Permeability Transition for Cytoprotection: Direct versus Indirect Mechanisms. | 2012 | Details |
| A45801 | 22672640 | Liver Int | Controlled attenuation parameter (CAP): a new device for fast evaluation of liver fat? | 2012 | Details |
| A45802 | 22658542 | Endocrinol Nutr | [Adolescence, obesity, and the role of lipoprotein lipases in the non-alcoholic fatty liver disease]. | 2012 | Details |
| A45803 | 22656328 | Gastroenterology | The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. | 2012 | Details |
| A45804 | 22652784 | Front Biosci (Landmark Ed) | Obesity-related hepatocellular carcinoma: roles of risk factors altered in obesity. | 2012 | Details |
| A45805 | 22648736 | J Cachexia Sarcopenia Muscle | Consilience in sarcopenia of cirrhosis. | 2012 | Details |
| A45806 | 22647274 | J Pharmacol Exp Ther | Differences in early acetaminophen hepatotoxicity between obese ob/ob and db/db mice. | 2012 | Details |
| A45807 | 22646861 | Expert Opin Drug Discov | Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk. | 2011 | Details |
| A45808 | 25755416 | J Clin Exp Hepatol | Non-alcoholic Fatty Liver Disease Progression: All Depends on the Inflammasome Deficiency Driven Dysbiosis. | 2012 | Details |
| A45809 | 25083232 | Ther Adv Drug Saf | Safety of statins: an update. | 2012 | Details |
| A45810 | 22641309 | Am J Gastroenterol | The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. | 2012 | Details |
| A45811 | 22620032 | Nihon Naika Gakkai Zasshi | [Programs for continuing medical education: A session; 2. Pathophysiology and treatment of nonalcoholic fatty liver disease]. | 2012 | Details |
| A45812 | 22614749 | Nat Rev Gastroenterol Hepatol | NAFLD: The role of exercise in treating NAFLD. | 2012 | Details |
| A45813 | 22612529 | J Vet Pharmacol Ther | Pharmacokinetics of pioglitazone in lean and obese cats. | 2012 | Details |
| A45814 | 22606437 | Case Rep Gastrointest Med | Unexplained findings of kayser-fleischer-like rings in a patient with cryptogenic cirrhosis. | 2012 | Details |
| A45815 | 22592130 | Metabolism | Sulfated oxysterol 25HC3S as a therapeutic target of non-alcoholic fatty liver disease. | 2012 | Details |
| A45816 | 22570973 | J Pediatr Endocrinol Metab | Hepatic dysfunction is associated with vitamin D deficiency and poor glycemic control in diabetes mellitus. | 2012 | Details |
| A45817 | 22560205 | Cell Metab | Cell Metabolism 2012 focus on lipids and insulin resistance. | 2012 | Details |
| A45818 | 22553843 | Zhonghua Gan Zang Bing Za Zhi | [Study on dysmetabolism in patients with non-alcoholic fatty liver disease and its different combinations]. | 2011 | Details |
| A45819 | 22550736 | Mayo Clin Health Lett | Nonalcoholic fatty liver disease. A growing health concern. | 2012 | Details |